Carregant...
The Economic Costs of Type 2 Diabetes: A Global Systematic Review
BACKGROUND: There has been a widely documented and recognized increase in diabetes prevalence, not only in high-income countries (HICs) but also in low- and middle-income countries (LMICs), over recent decades. The economic burden associated with diabetes, especially in LMICs, is less clear. OBJECTI...
Guardat en:
| Publicat a: | Pharmacoeconomics |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4519633/ https://ncbi.nlm.nih.gov/pubmed/25787932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-015-0268-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|